Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionKeystone Financial Group
Latest Disclosed Ownership3,863 shares
Latest Disclosed Value $ 537,213
Keystone Financial Group reports 11.84% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - Keystone Financial Group filed a 13F-HR form disclosing ownership of 3,863 shares of Gilead Sciences, Inc. (CH:GILD) valued at $537,213 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 4,382 shares of Gilead Sciences, Inc.. This represents a change in shares of -11.84% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES Equtities 375558103 3,863 -519 -11.84 537 0.00 0.0361
2026-02-06 2025-12-31 13F GILEAD SCIENCES Equities 375558103 4,382 -50 -1.13 538 8.70 0.0398
2025-11-17 2025-09-30 13F/A-1 GILEAD SCIENCES Common Stock 375558103 4,432 990 28.76 494 29.66 0.0378
2025-11-14 2025-09-30 13F GILEAD SCIENCES Common Stock 375558103 3,442 0 382 0.0303
2025-08-13 2025-06-30 13F GILEAD SCIENCES Common Stock 375558103 3,442 813 30.92 382 29.59 0.0344
2025-05-13 2025-03-31 13F GILEAD SCIENCES Common Stock 375558103 2,629 2,629 295 0.0299
2022-05-13 2022-03-31 13F GILEAD SCIENCES Common Stock 375558103 0 -3,182 -100.00 0 -100.00
2022-02-11 2021-12-31 13F GILEAD SCIENCES Common Stock 375558103 3,182 -700 -18.03 231 -14.76 0.0379
2021-11-12 2021-09-30 13F GILEAD SCIENCES Common Stock 375558103 3,882 -300 -7.17 271 -5.90 0.0490
2021-08-13 2021-06-30 13F GILEAD SCIENCES Common Stock 375558103 4,182 0 0.00 288 6.67 0.0522
2021-05-11 2021-03-31 13F GILEAD SCIENCES Common Stock 375558103 4,182 -35 -0.83 270 9.76 0.0526
2021-02-10 2020-12-31 13F GILEAD SCIENCES Common Stock 375558103 4,217 160 3.94 246 -3.91 0.0512
2020-11-13 2020-09-30 13F GILEAD SCIENCES Common Stock 375558103 4,057 -594 -12.77 256 -28.49 0.0628
2020-08-13 2020-06-30 13F GILEAD SCIENCES Common Stock 375558103 4,651 -1,168 -20.07 358 -17.70 0.0973
2020-05-05 2020-03-31 13F/A-1 GILEAD SCIENCES Common Stock 375558103 5,819 2,096 56.30 435 79.75 0.1442
2020-05-05 2020-03-31 13F GILEAD SCIENCES Common Stock 375558103 3,723 0 242 65,013.9162
2020-02-06 2019-12-31 13F GILEAD SCIENCES Common Stock 375558103 3,723 -196 -5.00 242 -2.42 0.0650
2019-11-07 2019-09-30 13F GILEAD SCIENCES Common Stock 375558103 3,919 363 10.21 248 3.33 0.0763
2019-08-07 2019-06-30 13F GILEAD SCIENCES Common Stock 375558103 3,556 -90 -2.47 240 1.27 0.0781
2019-05-07 2019-03-31 13F GILEAD SCIENCES Common Stock 375558103 3,646 3,646 237 0.0843
2019-02-11 2018-12-31 13F GILEAD SCIENCES Common Stock 375558103 0 -2,867 -100.00 0 -100.00
2018-11-06 2018-09-30 13F GILEAD SCIENCES Common Stock 375558103 2,867 2,867 224 0.0917
2018-08-14 2018-06-30 13F GILEAD SCIENCES Common Stock 375558103 0 -2,913 -100.00 0 -100.00
2018-05-15 2018-03-31 13F GILEAD SCIENCES Common Stock 375558103 2,913 -298 -9.28 213 -10.88 0.1183
2018-02-09 2017-12-31 13F GILEAD SCIENCES Common Stock 375558103 3,211 3,211 239 0.1485
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.